Acelrx Pharmaceuticals reported $71.97M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acelrx Pharmaceuticals ACRX:US $ 71.97M 5.92M
Acura Pharmaceuticals ACUR:US 1.9M 22K
Baxter International BAX:US $ 32716M 805M
Becton, Dickinson and BDX:US $ 54786M 1423M
Cara Therapeutics CARA:US $ 223.87M 23.19M
Heron Therapeutics HRTX:US $ 273.72M 31.98M
Intra Cellular Therapies ITCI:US $ 868.58M 378.66M
Johnson & Johnson JNJ:US $ 178355M 3663M
Pain Therapeutics PTIE:US $ 244.19M 22.59M
Smiths SMIN:LN 5.88B 543M
Teva Pharmaceutical TEVA:IT 47.06B 607M
Xeris Pharmaceuticals Inc XERS:US $ 337.62M 33.26M